(Press-News.org) A study suggests that states with stricter school meal nutrition standards were associated with better weight status among students who received free or reduced-price lunches compared with students who did not eat school lunches, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
The National School Lunch Program (NSLP) was started in 1946 to improve student nutrition by providing school lunches according to standards sets by the U.S. Department of Agriculture (USDA). However, the program has faced criticism that the lunches did not meet USDA nutrient-based standards, and the NSLP may be a missed opportunity to improve students' weight status and reduce the health consequences of obesity, the authors write in the study background.
Daniel R. Taber, Ph.D., of the University of Illinois at Chicago and colleagues conducted a study using a sample of 4,870 students in 40 states. Student data were obtained from the Early Childhood Longitudinal Study, Kindergarten Class, which began collecting data from a nationally representative sample of kindergarten students in fall 1998.
In states that exceeded USDA school meal standards, the difference in obesity prevalence between students who received free or reduced-price lunches and students who did not get lunches was 12.3 percentage points smaller compared with states that did not exceed USDA standards.
"In states that did not exceed USDA standards, students who obtained free/reduced-price lunches were almost twice as likely to be obese than students who did not obtain school lunches (26 percent and 13.9 percent, respectively), whereas the disparity between groups was markedly reduced in states that exceeded USDA standards (21.1 percent and 17.4 percent, respectively)," according to the study results.
Researchers also found that there was little evidence that students compensated for school meal laws by buying sweets, salty snacks or sugar-sweetened beverages from other school venues, such as vending machines, or from other sources, such as fast food restaurants.
"The evidence in this study suggests that ongoing changes to school meal standards have the potential to reduce obesity, particularly among students who are eligible for free/reduced-price lunches, though additional longitudinal research is needed to confirm this," the study concludes.
(JAMA Pediatr. Published online April 8, 2013. doi:10.1001/jamapediatrics.2013.399. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Support for the research was provided by The Robert Wood Johnson Foundation and a grant from the National Heart, Lung and Blood Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: School Meals a Starting Point for Countering Childhood Obesity
In a related editorial, Marion Nestle, Ph.D., M.P.H., of New York University, writes: "In this issue of JAMA Pediatrics, Taber and colleagues provide important evidence to support the value of strong, far-reaching public health initiatives to counter childhood obesity."
"In short, the study found an association between more stringent school meal standards and more favorable weight status, especially among low-income students," Nestle continues.
'The study produced one other noteworthy result. Students did not compensate for the healthier school meals by buying more snacks or sodas on school premises," Nestle concludes.
(JAMA Pediatr. Published online April 8, 2013. doi:10.1001/jamapediatrics.2013.404. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
### END
Strict school meal standards associated with improved weight status among students
2013-04-09
ELSE PRESS RELEASES FROM THIS DATE:
Pre-pregnancy body fat, in-pregnancy weight gain, and gestational diabetes combine to increase risk of high birthweight babies to differing degrees in white, black, Hispanic, and Asian women
2013-04-09
A new study shows that a woman's pre-pregnancy body fat (adiposity), in-pregnancy weight gain, and presence of gestational diabetes mellitus (GDM) can all combine to steeply increase the risk of giving birth to large-for-gestational age (LGA) babies to different degrees in white non-Hispanic, black non-Hispanic, White Hispanic, and Asian women, with the highest combined risk being in White non-Hispanic women. The research is published in the journal Diabetologia (the journal of the European Association for the Study of Diabetes) and is led by Dr Katherine Bowers and Dr ...
Environmental change triggers rapid evolution
2013-04-09
A University of Leeds-led study, published in the journal Ecology Letters, overturns the common assumption that evolution only occurs gradually over hundreds or thousands of years.
Instead, researchers found significant genetically transmitted changes in laboratory populations of soil mites in just 15 generations, leading to a doubling of the age at which the mites reached adulthood and large changes in population size. The results have important implications in areas such as disease and pest control, conservation and fisheries management because they demonstrate that ...
Adding intestinal enzyme to diets of mice appears to prevent, treat metabolic syndrome
2013-04-09
Feeding an intestinal enzyme to mice kept on a high-fat diet appears to prevent the development of metabolic syndrome – a group of symptoms associated with type 2 diabetes, cardiovascular disease and fatty liver – and to reduce symptoms in mice that already had the condition. In their report published online in PNAS Early Edition, Massachusetts General Hospital (MGH) investigators describe how dietary supplementation with intestinal alkaline phosphatase (IAP) reduced the inflammation believed to underlie metabolic syndrome by blocking a toxic molecule found on the surface ...
Nearly half of breast cancer patients at risk of having BRCA mutations not sent for genetic testing
2013-04-09
WASHINGTON, DC -- Only 53 percent of newly diagnosed breast cancer patients who were at high risk of carrying a BRCA 1 or BRCA 2 mutation – based on age, diagnosis, and family history of breast or ovarian cancer – reported that their doctors urged them to be tested for the genes, according to a research team from the Perelman School of Medicine at the University of Pennsylvania.
The findings, which will be presented during the American Association for Cancer Research Annual Meeting 2013 (Presentation #1358), were drawn from surveys completed by 2,258 women between 18 ...
Adding cetuximab to chemotherapy enables select patients with advanced colorectal cancer and liver metastasis to undergo surgery, extending survival by several months
2013-04-09
In this News Digest:
Summary of a study being published online April 8, 2013 in the Journal of Clinical Oncology, reports that adding cetuximab (Erbitux) to chemotherapy enabled previously inoperable patients to undergo surgery, tripling the rates of successful surgery for liver metastasis.
The combination of cetuximab and chemotherapy extended median overall survival for this population of patients by 10 months compared with chemotherapy alone.
Quote for attribution to Neal Meropol, MD, American Society of Clinical Oncology Cancer Communications Committee member ...
Month of birth impacts on immune system development
2013-04-09
Newborn babies' immune system development and levels of vitamin D have been found to vary according to their month of birth, according to new research.
The research, from scientists at Queen Mary, University of London and the University of Oxford, provides a potential biological basis as to why an individual's risk of developing the neurological condition multiple sclerosis (MS) is influenced by their month of birth. It also supports the need for further research into the potential benefits of vitamin D supplementation during pregnancy.
Around 100,000 people in the ...
Study finds key to calling back-up help when tumor-fighter p53 goes down
2013-04-09
WASHINGTON, D.C. – Tumor suppression, the family business of the sibling genes p53, p63 and p73, is undermined from within by the split personalities of p63 and p73, which each produce protein forms that not only block the work of the other two genes but also shut down its own cancer-stifling fraternal twin.
In a presentation at the AACR Annual Meeting 2013, scientists from The University of Texas MD Anderson Cancer Center demonstrate that tumor suppression can be restored in mice that lack p53 by knocking out the ∆N isoforms of p63 and p73 that interfere with tumor ...
AACR news: XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants
2013-04-09
The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. The results of this preclinical work are presented at the AACR Annual Meeting 2013.
"With molecularly targeted agents, we typically see 3 or 4 CRC explant models with a significant decrease in tumor growth. Here we have a drug that was active in every explant we tested. It's really exciting," says John Arcaroli, PhD, investigator at the University ...
AACR news: Autophagy-addicted breast cancers killed by anti-malaria drug, chloroquine
2013-04-09
The process of autophagy cleans cells – they wrap up the bad stuff and then dispose of it. And so it stands to reason that inhibiting autophagy would make cancer cells less able to cleanse themselves of chemotherapy and so more susceptible to the drugs. That's what the traditional anti-malaria drug, chloroquine, does – it inhibits autophagy. Existing clinical trials are testing chloroquine/chemotherapy combinations against breast cancer.
Research presented at the AACR Annual Meeting 2013 shows that some breast cancer subtypes depend on autophagy more than others – and ...
Possible predictive biomarker for patients who may respond to autophagy inhibitors
2013-04-09
WASHINGTON, DC – Autophagy, the process by which cells that are starved for food resort to chewing up their own damaged proteins and membranes and recycling them into fuel, has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation. Using drugs to shut down that survival mechanism shows great promise, especially when combined with targeted agents and standard chemotherapies, but until recently, it has been unclear which patients' cancers would respond to that combination therapy.
A team led by researchers from the ...